The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
NCT ID: NCT01342614
Last Updated: 2011-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2006-05-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
NCT02438397
The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus
NCT00463502
Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
NCT03590262
The Effects of Metformin on Blood Vessel Structure and Function
NCT00105066
Metformin for the Treatment of Diabetes in Pregnancy
NCT00414245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fosinopril group
Fosinopril group received fosinopril, 10mg, once per day.
Fosinopril
Fosinopril group received fosinopril, 10mg, once per day.
Metformin group
Metformin group was treated with metformin hydrochloride, 500mg, three times per day
Metformin
Metformin group was treated with metformin hydrochloride, 500mg, three times per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fosinopril
Fosinopril group received fosinopril, 10mg, once per day.
Metformin
Metformin group was treated with metformin hydrochloride, 500mg, three times per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* duration of hypertension was \<5 years
* overweight or obesity, mild to moderate hypertension, receive no euglycemic agent or antiobesity drug
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
China-Japan Friendship Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MET140
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.